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Sunlmary 
In T  lymphocytes,  triggering of the T cell receptor (TCR) induces several signaling cascades 
which ultimately synergize to induce the activity of the nuclear factor of activated T cells (NFAT), 
a DNA binding complex critical to the inducibility and T cell specificity of the T cell growth 
factor interleukin 2. One immediate consequence of T cell activation via the TCR is an increase 
in cytosolic calcium. Calcium signals are important for NFAT induction, and recent studies have 
identified calcineurin, a calcium-calmodulin  dependent serine-threonine phosphatase, as a prominent 
component of the calcium signaling pathway in T ceils. A second important molecule in TCR 
signal transduction is the guanine nucleotide binding protein, p21 r~, which is coupled to the 
TCR by a protein tyrosine kinase dependent mechanism. The experiments presented here show 
that expression by transfection of mutationally activated calcineurin or activated p21 r~ alone is 
insuffident for NFAT transactivation.  However, coexpression of the activated calcineurin with 
activated p21  r~ could mimic TCR signals in NFAT induction. These data identify calcineurin 
and p21 ~as as cooperative partners  in T  cell activation. 
T  lymphocyte  growth is controlled by the cytokine inter- 
leukin 2 (IL-2). Quiescent T  cells do not express the 
IL-2 gene (1). After T cell activation via the T cell receptor 
for antigen (TCR), there is transcriptional induction of IL-2 
gene expression (2). The target for TCR-derived signals in 
the IL-2 gene is a T cell-specific transcriptional enhancer lo- 
cated in a region 275 bp 5' of the gene (3). The cooperative 
activity of at least eight proteins that interact with this en- 
hancer appears to control IL-2 gene transcription  (4). Several 
of these proteins, such as AP-1, NFxB, and Oct-1 are ubiqui- 
tous and regulate gene transcription  in many cells. However, 
a protein complex termed the nudear factor of activated T 
cells (NFAT) 1 has been identified that seems to determine 
both the T cell specificity and inducibility of IL-2 gene regn- 
lation (5). In particular, NFAT is a specific  target for the TCR- 
derived signals that control IL-2 gene expression. NFAT is 
thought to be composed of two proteins: one is T cell-specific, 
cytoplasmic, and translocates to the nucleus upon T cell acti- 
vation; the other is apparently a member of the APl family 
of transcriptional  factors (i.e., Fos/Jun), predominantly nu- 
clear, and present  only in activated cells (6-10). 
The expression of a functional NFAT complex in T cells 
1 Abbreviations used in this paper: CAT, chloramphenicol acetyl transferase; 
CNA, wild type calcineurin A subunit; CNB, wild type calcineurin  B 
subunit; CNM, calcineurin A mutant; NFAT, nuclear factor of activated 
T  cells; PKC, protein kinase C; IrI'K, protein tyrosine kinase. 
is controlled by synergistic signaling pathways initiated by 
the TCR (11). The immediate signaling consequences  of TCR 
triggering include  activation  of protein  tyrosines  kinases 
(PTKs), which facilitates the rapid elevation of intracellular 
calcium concentration and activation of  protein kinase C (PKC) 
(12). Calcium and PKC are important signals in T cell acti- 
vation  since pharmacological  agents such as calcium iono- 
phores and phorbol esters, that elevate intracellular calcium 
and activate PKC, respectively, can bypass the requirements 
for TCR triggering and synergize  to induce a functional NFAT 
complex (13, 14). 
A third signaling pathway that involves the guanine nucleo- 
tide binding proteins  p21 ~s also originates  from the TCR 
(15-18). The Ras proteins rapidly accumulate in an activated 
GTP-bound state upon TCR triggering and also in response 
to stimulation of PKC. However, although the TCR induces 
PKC activation, PKC does not appear to mediate TCR regu- 
lation of p21 r~s (19). Instead, the TCR couples to p21 r~s via 
a PKC-independent  mechanism requiring the integrity of 
TCR-regulated PTKs. 
In recent studies, it has been shown that Ras function is 
essential for TCR signal transduction as  judged by the demon- 
stration that expression of a dominant inhibitory mutant of 
p21 ra~, N17 ras, prevents TCR induction of NFAT and the 
IL-2 gene (20, 21). Moreover, expression of a constitutively 
activated Ras protein,  p21 v'H  .... ,  has a dominant positive 
effect on NFAT induction and is able to generate a signal 
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that mimics the TCR response. The calcium-regnlated  signals 
that cooperate with p21 ra~ to induce NFAT have not yet been 
identified. However, a component of the calcium signal that 
is essential  for TCR induction of NFAT has recently been 
identified. The calcium-calmodulin dependent phosphatase 
calcineurin (22-25),  which is the major cellular  target for 
the immunosuppressive drugs cyclosporin A and FK506 in 
vivo, is activated in response to TCR triggering or stimula- 
tion of cells with calcium ionophore (26).  The expression 
of a truncated constitutively active Ca  2  +-indePendent cata- 
lytic subunit ofcalcineurin generates a signal that can substi- 
tute for calcium signals  and synergize with phorbol esters 
to induce the IL-2 gene (22).  Overexpression of wild type 
calcineurin can also augment TCR-induced NFAT-dependent 
transcription (23). 
The potential for p21TM to cooperate with calcineurin has 
not yet been explored, but activation of ras is a good candi- 
date for the physiological partner for calcineurin in NFAT 
induction for at  least  two reasons.  First,  p21 ~'~, like cal- 
cineurin, has an essential function in TCK regulation of  NFAT 
(21).  Second,  p21 ras  can  replace  some  requirements  .for 
phorbol ester activation of PKC in NFAT induction. Accord- 
ingly, the object of the present study was to examine the 
potential for p21 ~  and calcineurin to synergize during T cell 
activation and substitute for the TCR in the induction of 
NFAT. The present data show that in two T  cell lines, the 
human leukemia Jurkat and the murine thymoma EL4, ex- 
pression  of either constitutively active p21 ~'~ or a constitu- 
tively active calcineurin is not alone sufficient for NFAT tran- 
scription.  However,  in  combination,  activated p21 ~s  and 
calcineurin can synergize to give induction of NFAT that 
mimics the response  induced by TCR. These data further 
define TCK signal transduction as involving cooperative in- 
teractions between  signals  by calcineurin and p21 ~'~ con- 
trolled signaling pathways. 
Materials  and Methods 
Reagents.  Ionomycin (calcium salt) and  phorbol-12,  13-di- 
butyrate were from Calbiochem Corp. (UK). UCHT1 (reactive 
for human CD3)  was used at  10 ~g/ml in culture (27). [uC]- 
Acetyl coenzyme A (at 50-60 mCi/mmol) was from Amersham 
International (Buckinghamshire, LrK). 
Cells and Transfections.  The human T leukemia,  Jurkat, and the 
murine cells EL4 were maintained in RPMI 1640 supplemented 
with 10%  heat-inactivated FCS. Growth was at 37~  and hu- 
midified in 5%  CO2/95%  air. Cells were transfected via dec- 
troporation (Gene Pulser; Bio-Rad Laboratories, UK), according 
to the manufacturer's instructions. Briefly,  Jurkat cells were pulsed 
(2  x  107/ml) in media +  serum, at 960 ~F and 310 V. EL4 cells 
(supplemented with 10 ~M B-me for growth),  at 108/ml, were 
pulsed at 250 V and 960/~F. Cultures were transfected and im- 
mediately stimulated, as necessary, for 24 h. 
Phsmids.  I1.2  chloramphenicol acetyl transferase (CAT) (11), 
and NFAT CAT (5) have  been previously  described. IL-2 CAT con- 
tains regulatory sequences upstream of the I1,2 gene (from - 326 
to  +47),  that include the I1,-2 minimal promoter and enhancer, 
directing transcription of the reporter gene. NFAT CAT contains 
three  copies of  the  sequence  5'  GGAGGAAAAACTGTTT- 
CATACAGAAGC~GT  3' (corresponding to the sequence from po- 
sition  -284 to  -258 relative to the start of transcription of the 
11.2 gene) upstream of the I1.2 minimal promoter driving the 
reporter gene CAT. This sequence  has been identified  as the binding 
site for NFAT, the ARRE-2 site of the human I1.,2 enhancer (3). 
I1,2 mpCAT is a deletion mutant of NFAT CAT in which the 
binding sites for NFAT have  been deleted, leaving the I1,2 minimal 
promoter to drive CAT activity. The sequence of the I1,2 minimal 
promoter was confirmed by ds sequencing (Sequenase, version 2.0; 
United States Biochem.  Corp., Cleveland,  OH). The construct used 
for the expression of activated Ras was created by inserting the 
0.7-kb BamHI fragment of CMVras (21) into the BamHI site of 
pEF BOS (28). Orientation was determined by restriction analysis 
and activity was assessed in a focus forming assay. CNA and CNB 
have been described (22), and are expressed under the control of 
the SRc~ promoter  of HTLV-1 (23). CNM is a truncation  of 
CNAo~4, in which a stop codon has been introduced at aa397, 
resulting in a constitutively active, Ca2+-independent phospha- 
tase (29). 
CAT Assays.  Assays  were performed according to the method 
of Sleigh et al. (30), with modifications. Briefly, cells were lysed 
in 100 #1 of 0.65% NP-40, 10 mM "iris, pH 8.0, 1 mM EI~A, 
150 mM NaC1, for 10 min on ice. Cellular debris was pelleted, 
and the lysate  heat was treated at 68~  for 10 min before use. Assay 
conditions were 150 mMTris, pH 8.0, 0.05/~Ci [14C]acetyl  coen- 
zyme A, and 2 mM chloramphenicol. Chloramphenicols were ex- 
tracted with ethyl acetate, and the amount of radioactivity in the 
acetylated products and nonacetylated substrate of each reaction 
was determined by liquid scintillation counting  of organic and 
aqueous phases, respectively. 
Results 
A  Constitutively Active Mutant ofCakineurin Synergizes with 
Phorbot Esters to Regulate NFAT.  To monitor NFAT activity, 
we employed transient transfection and quantitation of the 
expression  of a CAT reporter gene whose activity is regu- 
lated by a trimer of the NFAT binding site, located upstream 
of the IL-2 minimal promoter. The signaling requirements 
for expression of this transfected NFAT reporter gene in Jurkat 
cells have been described  (3, 6,  13). Ionomycin, which ele- 
vates intraceUular calcium, and Pdbu, which activates PKC, 
synergize for maximal NFAT induction (Fig.  1 a). 
To examine the effect of calcineurin on NFAT, Jurkat cells 
were cotransfected with NFAT CAT plus one or a combina- 
tion of calcineurin expression constructs: CNAo~ 4, the wild 
type catalytic subunit of calcineurin (CNA); a wild type cal- 
cineurin B subunit (CNB), or the constitutively active cal- 
cineurin A mutant (CNM). The latter is a deletion mutant 
of the calcineurin catalytic subunit, calcineurin A~x4, that 
lacks functional calmodulin binding and autoinhibitory do- 
mains, and has CaZ+-independent constitutive phosphatase 
activity in vitro (29). The data show that expression of wild 
type CNA and CNB either alone or in combination does 
not induce a marked activation of NFAT CAT. As described 
previously,  ionomycin alone has a slight stimulatory effect 
that is enhanced in cells transfected with the combination 
of CNA and CNB (23). 
IMBu alone has no apparent stimulatory effect, but the most 
striking observation was the strong synergy  between the CNM 
and Pdbu that resulted in a level of NFAT induction com- 
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(Fig.  1  b). 
v-Ha-ms  Synergizes  with Cakium Ionophore  to Regulate  NFAT 
CAT inJurkat Cells.  p21  v-H  ..... is mutated at codon 12 and 
59 (31). These mutations render the Ras proteins insensitive 
to the Ras-GTPase activating proteins such that the Ras ac- 
cumulates in cells in an "active" GTP-bound state (32). When 
expressed in the murine thymoma EL4, signals generated by 
p21  v-H  ....  synergized  with  either  the  calcium  ionophore 
ionomycin or the PKC activator Pdbu to induce NFAT (21). 
The Jurkat  cells used in the present  study differ from EL4 
cells in their activation response to Pdbu (33). Hence in EL4 
cells,  PKC activation alone is  sufficient for NFAT activity, 
whereas in Jurkat cells there is an apparent obligatory require- 
ment for calcium signals for NFAT induction (11).  The data 
in Fig.  2 a  show the characteristics  of NFAT regulation in 
Jurkat  cells  cotransfected with  NFAT CAT and p21  ~-H  ..... . 
The mutationally activated Ras alone had a stimulatory effect 
on NFAT that was not further enhanced by PdBu treatment 
of the cells.  However, p21 ~H  .... generated a strong synergy 
with ionomycin to induce levels of NFAT comparable to that 
seen  in  ionomycin  and  PdBu-treated  cells.  The  fact  that 
p21  r~s alone only elicits  a weak  stimulation  of NFAT CAT 
Figure  1.  Constitutively activated calcineurin synergizes  with phorbol 
ester to regulate NFAT  transcriptional activity. (a)Jurkat cells were trans- 
fected with NFAT CAT and calcineurin expression vectors either alone, 
or in combination was described in Materials and Methods. lonomycin 
was used at 0.5/~g/ml and PdBu at 50 ng/ml, as indicated. Here, 10 #g 
of reporter construct was used in concert with 10/~g of each calcineurin 
construct. Cells were electroporated  and stimulated immediately  after trans- 
fection for 24 h before cytosolic extracts were made and reporter gene 
activity was assessed. Percent conversion represents the ratio of radioac- 
tivity extracted in the organic phase vs. total radioactivity  in organic plus 
aqueous phases. ([7) control -  NFAT CAT alone; ([]) CNA -  NFAT 
CAT +  10/*g wt CNA; ([~) CNB  -  NFAT  CAT +  10 #g wt CNB; 
(~) CNA + CNB -  NFAT  CAT +  10 #*g wt CNA +  10/~g  wt CNB; 
(.) CNM -  NFAT  CAT +  10/*g CNM. The data shown are represen- 
tative of more than five experiments. Percent conversion in control un- 
stimulated samples ranged from 2.4 to 7.7%. (b) Jurkat cells were trans- 
fected with 2/~g of AP-1 CAT and 20/~g of CNM or not (control). ([]) 
=  control unstimulated cells; (I)  =  Pdbu 50 ng/ml. Fold induction is 
the ratio of activity (% conversion)  in stimulated cells vs. control unstimu- 
lated cell (no added CNM). The data shown are representative of three 
experiments. Percent conversion  in control unstimulated cells ranged from 
1.0 to 5.9%. 
parable to that observed in response to ionomycin plus Pdbu 
(Fig.  1 a).  These data indicate that the CNM but not wild 
type CNA or CNB can substitute for ionomycin-induced cal- 
cium  signals  in  the regulation  of NFAT.  The effect of the 
CNM on NFAT activity was selective as judged by two in- 
dependent observations. First, the CNM did not enhance ex- 
pression of a CAT reporter gene driven by the IL-2 minimal 
promoter alone (data not shown). Second, the CNM had no 
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Figure  2.  v-Ha-ras  regulates NFAT  CAT and AP-1 CAT inJurkat cells. 
(a) Jurkat cells were transfected with  10 t~g NFAT CAT, and 40 k~g of 
EF empty vector (control) or EF v-Ha-ras (v-Ha-ras). Stimulation was as 
in Fig. 1: (I-l) unstimulated, (1~) iono, (~) Pdbu, (@) iono  +  Pdbu. 
Activity was as in Fig. 1. The data shown are representative of three ex- 
periments. Percent conversion  in control unstimulated samples as per Fig. 
1 a. (b) Jurkat cells were transfected with 2/zg of AP-1 CAT and 20 ~g 
of EF empty (control) or 20/~g EF v-Ha-ras (v-Ha-ras). Stimulation, (D) 
control, unstimulated or (m) PdBu treated, and activity are as described 
in Fig. 1. The data shown are representative of four experiments. Percent 
conversion in control unstimulated samples ranged from 1.2 to 5.9%. and  also that  Ras does not  synergize with PdBu was not 
due  to  insufficient  expression  of Ras.  Thus,  the  level  of 
p21 v'H'~ expressed in these experiments was alone sufficient 
to stimulate maximal levels of AP-1 activity, i.e., comparable 
to the level of AP-1 activity induced in response to PKC stim- 
ulation with  phorbol ester (Fig.  2  b). 
Cakineurin and p21 ~ Synergize to Regulate NFAT. p21  v-m'~s 
and CNM can both generate signals that regulate NFAT, but 
these signals appear to differ.  CNM synergizes with PKC, 
but not calcium controlled signals to regulate NFAT, whereas 
p21 ~m-'~ has the converse ability to synergize with calcium, 
but not PKC-controlled  pathways.  To examine the poten- 
tial for p21 r.~ and calcineurin  to synergize in NFAT induc- 
tion, Jurkat cells were cotransfected with NFAT CAT and 
p21  ~-H'~ and CNM, either alone or in combination.  Data 
averaged from four experiments (Fig. 3) show that p21  ~'H  .... 
in combination with CNM induced a strong expression of 
NFAT comparable to that seen in response to either p21  ~-H'~ 
plus ionomycin or CNM plus Pdbu.  Both p21 "~ and cal- 
cineurin are activated in response to triggering of the TCR 
(15, 24, 25). The data show that p21 v-H'~ plus CNM also 
induced NFAT CAT to a level greater than that induced in 
response to TCR triggering with the CD3 antibody UCHT1 
(Fig.  3). 
The  regulatory  effect  of  p21 ~-H  .....  on  NFAT  is  not 
confined to Jurkat cells but also occurs in a murine T  cell 
EL4. The effect of calcineurin mutants on NFAT expression 
in cells other than Jurkat has not been explored in previous 
studies. The data in Fig. 4 show that in EL4 cells expression 
of CNM but not wild type CNA or CNB can synergize with 
Pdbu or p21 ~-H  .....  to  induce  NFAT.  Expression  of CNM 
alone induced only a weak NFAT response, but in combina- 
tion with Pdbu or with  the constitutively active Ras,  the 
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Figure  3.  Calcineurin synergizes with v-Ha-ras to regulate NFAT CAT 
in Jurkat cells. Jurkat cells were transfected with 10/~g NFAT CAT plus 
10/~g of v-Ha-ras or CNM or both, as indicated.  Stimuli are as indicated 
in Fig. 1; in addition,  UCHT1 (10 I~g/ml in culture)  was added as indi- 
cated. Percent maximum response represents the ratio of activity seen in 
samples vs. that in iono +  Pdbu-treated  cultures without added v-Ha-ras 
or CNM (mean iono +  pdbu  =  84.5  _+ 0.6%). Data are the mean from 
four experiments,  error bars represent SEM. Percent conversion in control 
unstimulated samples as per Fig.  1 a. 
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Figure  4.  Calcineurin synergizes with v-Ha-ras to regulate NFAT CAT 
in EL4 cells. EL4 cells were transfected with 20/~g of NFAT CAT and 
50/~g of either (V]) EF empty,  ([])  CNA, (~A) CNB, or (ll) CNM, 
as indicated.  Stimuli were applied and data are represented  as in Fig.  1. 
The figure  is representative  of two experiments. 
active calcineurin  mutant synergized to induce a level of NFAT 
activity similar to that induced in response to cell activation 
by ionomycin in combination  with Pdbu (Fig.  4). 
Discussion 
In T  lymphocytes, p21TM is stimulated via the TCR in a 
mechanism involving TCK inhibition of ras GTPase-activating 
proteins (ras-GAPs) (15, 18). One important role for the TCR 
is to control the expression and function of transcription factors 
such as NFAT, that contribute to the control of IL-2 gene 
transcription (6). Expression of a mutated constitutively ac- 
tivated p21 '~ induces a response in T  cells  that  can syner- 
gize with a calcium signal to modulate T  cell activation as 
judged by NFAT induction  (21, 34). Similarly,  overexpres- 
sion of two src-family kinases, p561ok and p59  fy", appear to 
be able to partially replace the calcium requirement  for in- 
duction of NFAT-directed transcription  (35, 36). The com- 
ponents of the calcium signaling pathway able to cooperate 
with p21 ras in T  cells to regulate NFAT have not been pre- 
viously determined. However, recent studies have established 
that calcineurin, which is regulated by increases  in cytosolic 
calcium, is essential for TCR signaling function (22, 23, 37). 
The data presented here show that expression of a truncated, 
constitutively active calcineurin in both a human leukemic 
T  cell line, Jurkat,  and in the murine thymoma,  EL4, can 
substitute for calcium signals and,  in synergy with an acti- 
vated  p21 r~,  stimulate  T  cells  to  induce  NFAT-mediated 
transcription. Previous studies have indicated that calcineurin 
can synergize with phorbol esters to induce NFAT and hence 
the IL-2 gene (22,  23).  The current  study identifies p21 r'~ 
as an alternative partner for calcineurin in T cell activation. 
NFAT is known to have a critical function in the regula- 
tion of the IL-2 gene (11, 21). However, the exact composi- 
tion of this transcriptional  factor is as yet unresolved.  It is 
proposed that  NFAT is a complex of at least two compo- 
nents: a T cell-specific cytosolic component that translocates 
to the nucleus in response to increases in cytosolic calcium, 
and a nuclear component,  expressed only in activated cells, 
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tional factors (6, 7, 9, 10). p21 ~  is well established as an in- 
ducer and regulator of AP-1 in fibroblasts (38). The present 
data confirm  that  p21 ~' is also able to induce AP-l-medi- 
ated transcription  in T  cells, whereas calcineurin has no ap- 
parent regulatory effect. It is most probable, therefore, that 
in  the  cooperation  between  p21 ras  and  calcineurin,  Ras 
would contribute to NFAT induction via control of AP-1 
proteins, while calcineurin would regulate NFAT by control 
of the subcellular localization of the calcium-responsive  NFAT 
subunit. This model for the cooperative interaction between 
calcineurin and Ras in NFAT induction warrants further ex- 
ploration.  One complication lies in the fact that  the AP-1 
proteins are a large heterogeneous family of transcriptional 
factors, which come together in various combinations of Fos 
and Jun homo- and heterodimers  to form functional com- 
plexes (39).  When T  cells are activated,  they express mul- 
tiple Fos and Jun proteins (40), and the identity of the par- 
ticular partners present in the AP-1 complex that contribute 
to  NFAT induction  is  not yet clear  (7,  9,  10). 
The downstream effectors of both p21TM and calcineurin 
are not known.  One potential  Ras regulated pathway that 
could contribute to NFAT regulation is the MAP kinase sig- 
naling  cascade (41).  p21 r~' can regulate  the  activity of the 
MAP kinase Erk2 in Jurkat  cells  (42).  Substrates for Erk2 
include transcriptional factors such as the AP1 member c-jun, 
and Elk-l, protein that complexes with serum response factor 
to transactivate  the c-fos promoter,  whose function is con- 
trolled by phosphorylation at target sites for the MAP kinase 
family (43-45). Thus, the MAP kinases could be integral to 
the signaling  pathways that  couple the TCR and p21 ,~ to 
the cell nucleus. 
The  potential  for  cooperation  between  p21 ~a,  and  ca1- 
cineurin  has not been observed in previous studies of Ras 
function in other cell types. However, the idea that Ras con- 
trolled signaling pathways are not alone sufficient for cell ac- 
tivation is not novel. For example, oncogenic transformation 
in fibroblasts requires a cooperative interaction between Ras 
and other oncogenes (46).  The demonstration  herein  that 
Ras and calcineurin  can cooperate to activate T  cells raises 
the possibility that calcineurin could be a protooncogene. Thus, 
mutations in calcineurin  or mutations that perturbed the regu- 
lation of calcineurin could be oncogenic if they occurred in 
cells  expressing oncogenic Ras. 
Defects in NFAT regulation have profound functional con- 
sequences for T  cells,  as judged by the immunosuppressive 
effects of the drugs cyclosporin A  and FK506 that  inhibit 
the action of calcineurin on NFAT induction (33). The real- 
ization that p21  TM is an important  partner with calcineurin 
in NFAT regulation suggests that Ras could also be an im- 
portant  target  for immunosuppression.  Alternatively,  any 
defects in Ras regulation would have severe immune conse- 
quences. This is supported by a recent study in nonobese dia- 
betic mice, in which mature (CD4+8 - , CD4-8 +) T  cells 
were not only unable to proliferate in response to TCK cross- 
linking,  but could not  demonstrate  activation  of p21 ra~ or 
p42maP  k after ligation  of the TCK (47).  Direct  stimulation 
of PKC was able to activate p21 r~,  and also to restore the 
cells' ability to grow in response to TCR signaling. This sug- 
gests  that  a defect must  exist between the  TCK  and  the 
p21 r~ proteins in these anergic cells, supporting the hypoth- 
esis that p21 r~ may play an important  role in the generation 
of an immune response.  However, it remains  to be seen if 
Ras defects exist in other anergic T  cell models or autoim- 
mune diseases. 
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